90 related articles for article (PubMed ID: 11584333)
21. Tedisamil blocks BK-type Ca(2+)-dependent K(+) channels and modulates action potentials in rat hippocampal neurons.
Church J; McLarnon JG
Neurosci Lett; 2002 Feb; 319(2):79-82. PubMed ID: 11825675
[TBL] [Abstract][Full Text] [Related]
22. Direct effects of colchicine on myocardial function: studies in hypertrophied and failing spontaneously hypertensive rats.
Cicogna AC; Robinson KG; Conrad CH; Singh K; Squire R; Okoshi MP; Bing OH
Hypertension; 1999 Jan; 33(1):60-5. PubMed ID: 9931082
[TBL] [Abstract][Full Text] [Related]
23. Effects of veratridine on the action potentials and contractility of right and left ventricles from normo- and hypertensive rats.
Nand V; Doggrell SA; Barnett CW
Clin Exp Pharmacol Physiol; 1997 Aug; 24(8):570-6. PubMed ID: 9269529
[TBL] [Abstract][Full Text] [Related]
24. [Is the bradycardic effect of tedisamil at the expense of the loss of the inotropic effect? A pressure-volume analysis with the conductance (volume) catheter technique in patients with coronary artery disease].
Thormann J; Mitrovic V; Strasser R; Pitschner HF; Riedel H; Bahavar H; Schlepper M
Z Kardiol; 1993 Apr; 82(4):211-21. PubMed ID: 8506715
[TBL] [Abstract][Full Text] [Related]
25. The in vivo electrophysiological actions of the new potassium channel blockers, tedisamil and UK 68,798.
Beatch GN; MacLeod BA; Abraham S; Walker MJ
Proc West Pharmacol Soc; 1990; 33():5-8. PubMed ID: 2274546
[No Abstract] [Full Text] [Related]
26. Cardiac electrophysiologic and antiarrhythmic actions of tedisamil.
Wallace AA; Stupienski RF; Baskin EP; Appleby SD; Kothstein T; Gehret JR; King SW; Remy DC; Lynch JJ
J Pharmacol Exp Ther; 1995 Apr; 273(1):168-75. PubMed ID: 7714763
[TBL] [Abstract][Full Text] [Related]
27. Antiarrhythmic properties of tedisamil (KC8857), a putative transient outward K+ current blocker.
Beatch GN; Abraham S; MacLeod BA; Yoshida NR; Walker MJ
Br J Pharmacol; 1991 Jan; 102(1):13-8. PubMed ID: 2043919
[TBL] [Abstract][Full Text] [Related]
28. In vivo evaluation of left ventricular function in aged SHR by volume loading and the positive inotropic effect of denopamine.
Ikeo T; Nagao T
Jpn J Pharmacol; 1986 May; 41(1):1-6. PubMed ID: 3735807
[TBL] [Abstract][Full Text] [Related]
29. Prolongation of monophasic action potential duration and the refractory period in the human heart by tedisamil, a new potassium-blocking agent.
Bargheer K; Bode F; Klein HU; Trappe HJ; Franz MR; Lichtlen PR
Eur Heart J; 1994 Oct; 15(10):1409-14. PubMed ID: 7821321
[TBL] [Abstract][Full Text] [Related]
30. Cardiac and hemodynamic effects of the sinus node inhibitor tedisamil dihydrochloride in patients with congestive heart failure due to dilated cardiomyopathy.
Hermann HP; Ohler A; Just H; Hasenfuss G
J Cardiovasc Pharmacol; 1998 Dec; 32(6):969-74. PubMed ID: 9869503
[TBL] [Abstract][Full Text] [Related]
31. Tedisamil. KC 8857.
Drugs R D; 1999 Apr; 1(4):327-30. PubMed ID: 10566055
[No Abstract] [Full Text] [Related]
32. Tedisamil (Solvay).
Flores NA
Curr Opin Investig Drugs; 2001 Jan; 2(1):97-103. PubMed ID: 11527020
[TBL] [Abstract][Full Text] [Related]
33. Ionic basis of action potential prolongation of hypertrophied cardiac myocytes isolated from hypertensive rats of different ages.
Cerbai E; Barbieri M; Li Q; Mugelli A
Cardiovasc Res; 1994 Aug; 28(8):1180-7. PubMed ID: 7954620
[TBL] [Abstract][Full Text] [Related]
34. Novel antiarrhythmic drugs in atrial fibrillation: focus on tedisamil.
Krishnamoorthy S; Lip GY
Expert Opin Investig Drugs; 2009 Aug; 18(8):1191-6. PubMed ID: 19604120
[TBL] [Abstract][Full Text] [Related]
35. Tedisamil inactivates transient outward K+ current in rat ventricular myocytes.
Dukes ID; Morad M
Am J Physiol; 1989 Nov; 257(5 Pt 2):H1746-9. PubMed ID: 2556052
[TBL] [Abstract][Full Text] [Related]
36. Antifibrillatory efficacy of long-term tedisamil administration in a postinfarcted canine model of ischemic ventricular fibrillation.
Friedrichs GS; Abreu JN; Driscoll EM; Borlak J; Lucchesi BR
J Cardiovasc Pharmacol; 1998 Jan; 31(1):56-66. PubMed ID: 9456278
[TBL] [Abstract][Full Text] [Related]
37. Influence of tedisamil on the initiation and maintenance of ventricular fibrillation: chemical defibrillation by Ito blockade?
Tsuchihashi K; Curtis MJ
J Cardiovasc Pharmacol; 1991 Sep; 18(3):445-56. PubMed ID: 1720845
[TBL] [Abstract][Full Text] [Related]
38. Actions and interactions of E-4031 and tedisamil on reperfusion-induced arrhythmias and QT interval in rat in vivo.
Bril A; Landais L; Gout B
Cardiovasc Drugs Ther; 1993 Apr; 7(2):233-40. PubMed ID: 8357777
[TBL] [Abstract][Full Text] [Related]
39. Modulation of cAMP level by tedisamil in guinea pig heart.
Tribulova N; Ravingerova T; Okruhlicova L; Gabauer I; Fickova M; Pancza D; Slezak J; Manoach M
Mol Cell Biochem; 2000 Jul; 210(1-2):75-80. PubMed ID: 10976760
[TBL] [Abstract][Full Text] [Related]
40. Rosuvastatin attenuates heart failure and cardiac remodelling in the ageing spontaneously hypertensive rat.
Loch D; Chan V; Hoey A; Brown L
Basic Clin Pharmacol Toxicol; 2009 Oct; 105(4):262-70. PubMed ID: 19583711
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
